share_log

Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $79

Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $79

Truist Securities保持對PROCEPT BioRobotics的買入評級,將目標價格上調至79美元。
Benzinga ·  07/16 09:55

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target from $72 to $79.

Truist Securities分析師Richard Newitter認爲PROCEPt BioRobotics(納斯達克代碼:PRCT)值得買入並將其目標價從72美元上調至79美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論